These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37552550)

  • 1. Evaluation of screening performance of first-trimester competing-risks prediction model for small-for-gestational age in Asian population.
    Nguyen-Hoang L; Papastefanou I; Sahota DS; Pooh RK; Zheng M; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Yapan P; Sim WS; Poon LC;
    Ultrasound Obstet Gynecol; 2024 Mar; 63(3):331-341. PubMed ID: 37552550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-trimester contingent screening for small-for-gestational-age neonate.
    Nowacka U; Papastefanou I; Bouariu A; Syngelaki A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):177-184. PubMed ID: 34214232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China.
    Hu J; Gao J; Liu J; Meng H; Hao N; Song Y; Ma L; Luo W; Sun J; Gao W; Meng W; Sun Y
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):529-539. PubMed ID: 33817865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Fetal Medicine Foundation competing-risks model for small-for-gestational-age neonate in early third trimester.
    Dagklis T; Papastefanou I; Tsakiridis I; Sotiriadis A; Makrydimas G; Athanasiadis A
    Ultrasound Obstet Gynecol; 2024 Apr; 63(4):466-471. PubMed ID: 37743681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of Fetal Medicine Foundation competing-risks model for midgestation prediction of small-for-gestational-age neonates in Spanish population.
    Albaiges G; Papastefanou I; Rodriguez I; Prats P; Echevarria M; Rodriguez MA; Rodriguez Melcon A
    Ultrasound Obstet Gynecol; 2023 Aug; 62(2):202-208. PubMed ID: 36971008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competing-risks model for prediction of small-for-gestational-age neonate from biophysical and biochemical markers at 11-13 weeks' gestation.
    Papastefanou I; Wright D; Syngelaki A; Souretis K; Chrysanthopoulou E; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):52-61. PubMed ID: 33094535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different methods of first-trimester screening for preterm pre-eclampsia: cohort study.
    Cuenca-Gómez D; De Paco Matallana C; Rolle V; Mendoza M; Valiño N; Revello R; Adiego B; Casanova MC; Molina FS; Delgado JL; Wright A; Figueras F; Nicolaides KH; Santacruz B; Gil MM
    Ultrasound Obstet Gynecol; 2024 Jul; 64(1):57-64. PubMed ID: 38411276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain.
    Cuenca-Gómez D; de Paco Matallana C; Rolle V; Valiño N; Revello R; Adiego B; Mendoza M; Molina FS; Carrillo MP; Delgado JL; Wright A; Santacruz B; Gil MM
    Ultrasound Obstet Gynecol; 2023 Oct; 62(4):522-530. PubMed ID: 37099759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?
    Noël L; Guy GP; Jones S; Forenc K; Buck E; Papageorghiou AT; Thilaganathan B
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):540-545. PubMed ID: 33998078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of angiogenic factors in prediction of growth-related neonatal morbidity at term and comparison with competing-risks model.
    Papastefanou I; Nobile Recalde A; Silva Souza Y; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 Apr; 63(4):457-465. PubMed ID: 37963283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.
    Chaemsaithong P; Pooh RK; Zheng M; Ma R; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Wataganara T; Yeo GSH; Wright A; Leung WC; Sekizawa A; Hu Y; Naruse K; Saito S; Sahota D; Leung TY; Poon LC
    Am J Obstet Gynecol; 2019 Dec; 221(6):650.e1-650.e16. PubMed ID: 31589866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of competing-risks model with angiogenic factors in midgestation screening for preterm growth-related neonatal morbidity.
    Papastefanou I; Menenez M; Szczepkowska A; Gungil B; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 May; 63(5):613-618. PubMed ID: 38057964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics, serum pregnancy-associated plasma protein-A and placental growth factor at 11-13 weeks' gestation.
    Papastefanou I; Wright D; Lolos M; Anampousi K; Mamalis M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):392-400. PubMed ID: 32936500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11-13 weeks' gestation: data from EVENTS trial.
    Benkő Z; Wright A; Rehal A; Cimpoca B; Syngelaki A; Delgado JL; Tsokaki T; De Alvarado M; Vojtassakova D; Malligiannis Ntalianis K; Chaveeva P; Del Campo A; De Ganzo T; Resta C; Atanasova V; Accurti V; Villalain C; Aguilera J; Dojcinovska D; O'Gorman N; Plasencia W; Zingler E; Dutemeyer V; Alvar B; Casanova MC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):257-265. PubMed ID: 33142361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-eclampsia screening in Denmark (PRESIDE): national validation study.
    Riishede I; Rode L; Sperling L; Overgaard M; Ravn JD; Sandager P; Skov H; Wagner SR; Nørgaard P; Clausen TD; Jensen CAJ; Pihl K; Jørgensen FS; Munk JK; Zingenberg HJ; Pedersen NG; Andersen MR; Wright A; Wright D; Tabor A; Ekelund CK
    Ultrasound Obstet Gynecol; 2023 Jun; 61(6):682-690. PubMed ID: 36840981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation.
    Mendoza M; Garcia-Manau P; Arévalo S; Avilés M; Serrano B; Sánchez-Durán MÁ; Garcia-Ruiz I; Bonacina E; Carreras E
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):84-90. PubMed ID: 32388877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for pre-eclampsia by maternal serum glycosylated fibronectin at 11-13 weeks' gestation.
    Sokratous N; Bednorz M; Sarli P; Morillo Montes OE; Syngelaki A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2023 Oct; 62(4):504-511. PubMed ID: 37401855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
    Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stratification of pregnancy care based on risk of pre-eclampsia derived from uterine artery Doppler at 19-24 weeks' gestation.
    Litwinska M; Litwinska E; Lisnere K; Syngelaki A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Jul; 58(1):67-76. PubMed ID: 33645854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.